Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,585 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination.
Heckl SM, Kercher L, Abdullazade S, Schneider C, Krüger S, Behrens HM, Sebens S, Schäfer H, Schreiber S, Röcken C. Heckl SM, et al. Among authors: schneider c. Cancers (Basel). 2021 Oct 5;13(19):4988. doi: 10.3390/cancers13194988. Cancers (Basel). 2021. PMID: 34638472 Free PMC article.
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer.
Schneeweis C, Diersch S, Hassan Z, Krauß L, Schneider C, Lucarelli D, Falcomatà C, Steiger K, Öllinger R, Krämer OH, Arlt A, Grade M, Schmidt-Supprian M, Hessmann E, Wirth M, Rad R, Reichert M, Saur D, Schneider G. Schneeweis C, et al. Among authors: schneider g, schneider c. Cell Mol Life Sci. 2022 Dec 19;80(1):12. doi: 10.1007/s00018-022-04638-y. Cell Mol Life Sci. 2022. PMID: 36534167 Free PMC article.
HDAC2 Facilitates Pancreatic Cancer Metastasis.
Krauß L, Urban BC, Hastreiter S, Schneider C, Wenzel P, Hassan Z, Wirth M, Lankes K, Terrasi A, Klement C, Cernilogar FM, Öllinger R, de Andrade Krätzig N, Engleitner T, Schmid RM, Steiger K, Rad R, Krämer OH, Reichert M, Schotta G, Saur D, Schneider G. Krauß L, et al. Among authors: schneider g, schneider c. Cancer Res. 2022 Feb 15;82(4):695-707. doi: 10.1158/0008-5472.CAN-20-3209. Cancer Res. 2022. PMID: 34903606 Free PMC article.
Epigenetic control of pancreatic cancer metastasis.
Krauß L, Schneider C, Hessmann E, Saur D, Schneider G. Krauß L, et al. Among authors: schneider g, schneider c. Cancer Metastasis Rev. 2023 Dec;42(4):1113-1131. doi: 10.1007/s10555-023-10132-z. Epub 2023 Sep 2. Cancer Metastasis Rev. 2023. PMID: 37659057 Free PMC article. Review.
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.
Hasselluhn MC, Schlösser D, Versemann L, Schmidt GE, Ulisse M, Oschwald J, Zhang Z, Hamdan F, Xiao H, Kopp W, Spitalieri J, Kellner C, Schneider C, Reutlinger K, Nagarajan S, Steuber B, Sastra SA, Palermo CF, Appelhans J, Bohnenberger H, Todorovic J, Kostyuchek I, Ströbel P, Bockelmann A, König A, Ammer-Herrmenau C, Schmidleitner L, Kaulfuß S, Wollnik B, Hahn SA, Neesse A, Singh SK, Bastians H, Reichert M, Sax U, Olive KP, Johnsen SA, Schneider G, Ellenrieder V, Hessmann E. Hasselluhn MC, et al. Among authors: schneider g, schneider c. Gastroenterology. 2024 Feb;166(2):298-312.e14. doi: 10.1053/j.gastro.2023.10.026. Epub 2023 Oct 31. Gastroenterology. 2024. PMID: 37913894
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
Orben F, Lankes K, Schneeweis C, Hassan Z, Jakubowsky H, Krauß L, Boniolo F, Schneider C, Schäfer A, Murr J, Schlag C, Kong B, Öllinger R, Wang C, Beyer G, Mahajan UM, Xue Y, Mayerle J, Schmid RM, Kuster B, Rad R, Braun CJ, Wirth M, Reichert M, Saur D, Schneider G. Orben F, et al. Among authors: schneider g, schneider c. JCI Insight. 2022 May 23;7(10):e151353. doi: 10.1172/jci.insight.151353. JCI Insight. 2022. PMID: 35439169 Free PMC article.
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.
Schneeweis C, Hassan Z, Ascherl K, Wirth M, Koutsouli S, Orben F, Krauß L, Schneider C, Öllinger R, Krämer OH, Rad R, Reichert M, Robles MS, Saur D, Schneider G. Schneeweis C, et al. Among authors: schneider g, schneider c. Cancer Commun (Lond). 2022 Apr;42(4):360-364. doi: 10.1002/cac2.12280. Epub 2022 Mar 7. Cancer Commun (Lond). 2022. PMID: 35253411 Free PMC article. No abstract available.
Stress granules-membraneless organelles as therapeutic targets in pancreatic cancer.
Schneider C, Schneider G. Schneider C, et al. Among authors: schneider g. EMBO Mol Med. 2024 Mar;16(3):429-431. doi: 10.1038/s44321-024-00040-2. Epub 2024 Feb 27. EMBO Mol Med. 2024. PMID: 38413839 Free PMC article.
In essence, these findings are supportive of targeting SGs as a therapeutic approach for PDAC (Santofimia-Castano et al, 2024). G. Schneider & C. Schneider discuss the study by Santofimia-Castano et al, in this issue of EMBO Mol. ...
In essence, these findings are supportive of targeting SGs as a therapeutic approach for PDAC (Santofimia-Castano et al, 2024). G. Schnei …
Engineering the Impact of Phonon Dephasing on the Coherence of a WSe_{2} Single-Photon Source via Cavity Quantum Electrodynamics.
Mitryakhin VN, Steinhoff A, Drawer JC, Shan H, Florian M, Lackner L, Han B, Eilenberger F, Tongay SA, Watanabe K, Taniguchi T, Antón-Solanas C, Predojević A, Gies C, Esmann M, Schneider C. Mitryakhin VN, et al. Among authors: schneider c. Phys Rev Lett. 2024 May 17;132(20):206903. doi: 10.1103/PhysRevLett.132.206903. Phys Rev Lett. 2024. PMID: 38829069
3,585 results